Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof
Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
08/1991
08/08/1991WO1991011525A2 Vaccines
08/07/1991EP0440219A1 cDNA corresponding to the genome of negative-strand RNA viruses, and process for the production of infectious negative-strand RNA viruses
08/06/1991US5038198 Modular semiconductor power device
08/06/1991US5037753 Feline t-lymphotropic lentivirus
08/06/1991US5037745 Genetic engineering
08/06/1991US5037650 Live combination vaccine
08/03/1991WO1991011460A1 Hepatitis a vaccines
08/03/1991CA2035386A1 Cdna corresponding to the genome of negative-strand rna viruses, and process for the production of infectious negative-strand rna viruses
08/01/1991DE4002521A1 Recombinant plasmids for pox virus transformation - contg. multifunctional DNA sequence cassette to facilitate cloning of foreign DNA
07/1991
07/31/1991EP0439056A2 Coccidiosis vaccines
07/30/1991CA2034564A1 Recombinant plasmid
07/27/1991WO1991011519A1 Recombinantly produced blood factors and process for the expression of said blood factors, as well as vaccinia virus recombinants used in said process
07/27/1991CA2073859A1 Recombinantly produced blood factors and process for the expression of said blood factors, as well as vaccinia virus recombinants used in said process
07/27/1991CA2034768A1 Recombinant coccidiosis vaccines - 5-7 eimeria surface antigen
07/25/1991WO1991010728A1 Novel retroviral vectors
07/24/1991EP0437604A1 Recombinant poxvirus and streptococcal m protein vaccine
07/24/1991EP0437516A1 H. saimiri-htlv-x region vector
07/23/1991CA1286619C Cell line producing aids viral antigens without producing infectious virus particles
07/20/1991CA2034533A1 Retroviral vectors
07/17/1991EP0179871B1 Method and cell line for continuous production of retroviruses (htlv-iii) related to aids
07/16/1991US5032520 Poultry
07/16/1991CA1286245C Insecticide making use of viruses and preparation process thereof
07/11/1991WO1991009940A1 Stable formulation of viral neuraminidase
07/10/1991CN1052896A Recombinant herpesvirus of turkeys and live vector vaccines derived thereof
07/09/1991US5030718 Against htlc, in pure form
07/09/1991US5030714 Isolated or synthetic peptide; diagnosis of aids
07/05/1991WO1991009937A1 Biomass for the production of viruses/virus antigens
07/03/1991EP0434747A1 Viral vaccines
07/03/1991EP0434721A1 Viral nucleotide sequences
07/03/1991EP0207984B1 Antiviral agents
07/02/1991US5028426 Deletion mutant of pseudorabies virus and vaccine containing said virus
06/1991
06/23/1991WO1991009935A1 Matrix with adherently bound cells and process for producing viruses/virus antigens
06/19/1991EP0432216A1 Recombinant retroviruses with amphotropic and ecotropic host ranges
06/19/1991EP0432196A1 Vaccine
06/19/1991CN1052331A Novel antigens and methods therefor
06/13/1991WO1991008214A1 Dna segment encoding a gene for a receptor related to the epidermal growth factor receptor
06/12/1991EP0431905A1 Method for purifying phage DNA
06/12/1991EP0431668A1 Recombinant herpesvirus of turkeys and live vector vaccines derived thereof
06/12/1991EP0431128A1 Self-assembled, defective, non-self-propagating viral particles
06/12/1991EP0431064A1 Recombinant vaccinia virus for prevention of disease caused by flavivirus
06/12/1991CN1052049A Process for preparing biologic resisting tumour
06/11/1991US5023182 Selected from nuclear polyhedrosis and granulosis viruses; non-sticky composition
06/04/1991US5021348 Attenuated hepatitis A virus
06/04/1991US5021347 DNA insert coding for a surface antigen
05/1991
05/29/1991EP0428656A1 Human cell line lc5 and its use.
05/28/1991US5019510 Isolation, molecular cloning and sequencing of an HIV-1 isolate from a Gabonese donor
05/21/1991US5017487 Genetic engineering
05/16/1991WO1991007419A1 Pneumocystis carinii dihydrofolate reductase gene and methods for its use
05/16/1991WO1991006658A2 Infective protein delivery system
05/16/1991CA2045184A1 Pneumocystis carinii dihydrofolate reductase gene and methods for its use
05/14/1991WO1991007482A1 Type-b rotavirus cultures and uses thereof
05/14/1991CA2068520A1 Type-b rotavirus cultures and uses thereof
05/02/1991WO1991005864A1 Production of genetically-engineered vaccines for aids and other retroviral diseases
04/1991
04/25/1991CA2067821A1 Infective drug delivery system using recombinant retroviral vectors
04/24/1991EP0423239A1 Post-transfusion, non-a, non-b hepatitis virus and antigens
04/24/1991CN1050899A Novel entities for cancer therapy
04/19/1991WO1991005569A1 Novel infectious bursal disease virus
04/19/1991CA2067397A1 Infectious bursal disease virus
04/18/1991WO1991002805A3 Recombinant retroviruses delivering vector constructs to target cells
04/17/1991WO1991005860A1 Non-infectious hiv-1 particles and uses therefor
04/17/1991CA2067778A1 Non-infectious hiv-1 particles and uses therefor
04/16/1991CA1283043C T-cell lymphotrophic virus protein and assay
04/11/1991DE3925748A1 New recombinant deoxyribonucleic acid - from foot=and=mouth disease virus, for prodn. of attenuated virus particles, useful in vaccines
04/10/1991EP0421635A1 Chimaeric hepadnavirus core antigen proteins
04/10/1991CN1050561A Recombinant adenovirus dna sequence, recombinant adenovirus expressing dna sequence and rhabdovirus vaccine including recombinant adenovirus
04/09/1991CA1282721C Herpes simplex virus as a vector
04/04/1991WO1991004324A1 Ribozyme compositions and methods for use
04/04/1991WO1991004319A1 Therapeutic ribozyme compositions and expression vectors
04/04/1991CA2066684A1 Therapeutic ribozyme compositions and expression vectors
04/04/1991CA2066647A1 Ribozyme compositions and methods for use
04/03/1991EP0419666A1 Promoter, plasmid containing the same, and recombinant avipoxvirus
04/03/1991EP0242380B1 A process for preparing immunogenic complex
04/02/1991US5004687 Genetically engineered insecticidal polypeptides
03/1991
03/30/1991WO1991005049A1 A recombinant birth control vaccine
03/21/1991WO1991003552A1 Recombinant negative strand rna virus expression systems and vaccines
03/21/1991DE3930510A1 Verfahren zur inaktivierung von viren in blut und blutprodukten A method for inactivation of viruses in blood and blood products
03/14/1991WO1991003933A1 Process for inactivating viruses in blood and blood products
03/07/1991WO1991002805A2 Recombinant retroviruses delivering vector constructs to target cells
03/07/1991WO1991002804A1 Recombinant adenovirus sequence expressing rhabdovirus antigen and use as a vaccine
03/07/1991WO1991002788A1 Herpes simplex virus type 1 mutant
03/06/1991EP0415731A2 Novel entities for cancer therapy
03/05/1991CA1280986C Thymidine kinase deletion mutants of bovine herpesvirus-1, vaccines against infectious bovine rhinotracheitis containing same and methods for the production and use of same
02/1991
02/27/1991EP0414475A1 Methods for culturing HCV in eukaryotic cells
02/27/1991EP0414374A2 Novel antigens and methods for their preparation
02/27/1991EP0414355A1 Feline interferon and process for production thereof by a silkworm virus vector
02/27/1991CN1049519A Pseudorabies virus not occurring in nature and vaccines containing same
02/26/1991WO1991002820A1 Methods for culturing hcv in eukaryotic cells
02/21/1991WO1991002054A1 Attenuated canine parvovirus (cpv), vaccine comprising cpv and method of preventing infection by cpv in dogs
02/21/1991WO1991002053A1 Low virulence laryngotracheitis (ilt) virus for vaccinating birds
02/19/1991US4994386 Production of HBLV virus in the HSB-2 cell line
02/18/1991WO1991002795A1 Mutant pseudorabies virus, and vaccines containing the same
02/18/1991CA2065002A1 Mutant pseudorabies virus, and vaccines containing the same
02/16/1991CA2000634A1 Vaccine against avian encephalomyelitis
02/12/1991US4992374 Mutant vaccinia virus and process for production thereof
02/12/1991US4992272 Inactivated virus which retains immunogenicity
02/07/1991WO1990015141A3 Self-assembled, defective, non-self-propagating viral particles
02/06/1991EP0411684A2 New antigenically active proteins/peptides, and feline infectious virus (FIPV)-vaccines
02/06/1991EP0231209B1 Virus vaccine
01/1991
01/30/1991EP0410748A1 Avipox virus promoters
01/30/1991EP0410713A1 Polypeptide inhibitor of viral replication
1 ... 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267